Graphex Group Limited (GRFX)
| Previous Close | 0.1832 |
| Open | 0.1831 |
| Bid | 0.1910 x 3000 |
| Ask | 0.1919 x 1000 |
| Day's Range | 0.1831 - 0.1929 |
| 52 Week Range | 0.1410 - 1.2200 |
| Volume | |
| Avg. Volume | 234,396 |
| Market Cap | 11.209M |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3800 |
| Earnings Date | Aug 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.40 |
GlobeNewswireUpdates on Graphex China Expansion Plan
Hong Kong, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Graphex Group Limited (“Graphex Group” or the “Company”) (NYSE American: GRFX | HKSE: 6128)) wishes to inform the shareholders and potential investors that the Company and Nanshu Town Government have intention of jointly working in the construction of the Phase 2 of graphite deep processing project (“Phase 2 Project”) located in the graphite industry cluster area of Nanshu Town, Laixi City, Qingdao, Shandong, PRC (“Location”). The Phase 2 Project will
- GlobeNewswire
Graphex Receives an Extension to Comply with the Continued Listing Requirements on the NYSE American
Hong Kong, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Graphex Group Limited (“Graphex Group” or the “Company”) (NYSE American: GRFX | HKSE: 6128)) announced today that it received an extension from the NYSE American LLC (the “Exchange”) for an additional period (the “Additional Cure Period”) to regain compliance with the NYSE American listing rules for American Depository Shares (ADS) on the Exchange until May 15, 2025 (the “New Cure Deadline”). The Company did not timely file with the Securities and Exc
